None listed
Conditions
Brief summary
Participants will be randomised to receive Coninuous positive Airway Pressure (CPAP) treatment with no humidification or humidification using thermosmartTM technology. After four weeks of treatment participants will be crossed over to the alternative arm of the study. They will complete four weeks on this arm. Participants will complete a subjective questionnaire after one night and at the end of each arm of treatment (i.e. weeks four and eight) weeks. At the end of four and eight weeks objective compliance will be obtained from the CPAP device.
Interventions
Participants will be randomised to receive Coninuous positive Airway Pressure (CPAP) treatment with no humidification or humidification using thermosmartTM technology. After four weeks of treatment participants will be crossed over to the alternative arm of the study. They will complete four weeks on this arm.
Participants will complete a subjective questionnaire after one night and at the end of each arm of treatment (i.e. weeks four and eight) weeks. At the end of four and eight weeks objecti
Participants will be randomised to receive Coninuous positive Airway Pressure (CPAP) treatment with no humidification or humidification using thermosmartTM technology. After four weeks of treatment participants will be crossed over to the alternative arm of the study. They will complete four weeks on this arm. Participants will complete a subjective questionnaire after one night and at the end of each arm of treatment (i.e. weeks four and eight) weeks. At the end of four and eight weeks objective compliance will be obtained from the CPAP device.
Sponsors
Fisher and Paykel Healthcare
Study design
Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients diagnosed with OSA by 3-channel ambulatoruy system and titrated using a ful overnight PSGRDI.
Exclusion criteria
Severe cardiac diseaseChronic pulmonary diseaseSignificant psychiatric illness.
Outcome results
None listed